Literature DB >> 34661816

Early onset of aging phenotype in vascular repair by Mas receptor deficiency.

Goutham Vasam1, Shrinidh Joshi S1, Su Yamin Miyat1, Hashim Adam1, Yagna P Jarajapu2.   

Abstract

Aging is associated with impaired vascular repair following ischemic insult, largely due to reparative dysfunctions of progenitor cells. Activation of Mas receptor (MasR) was shown to reverse aging-associated vasoreparative dysfunction. This study tested the impact of MasR-deficiency on mobilization and vasoreparative functions with aging. Wild type (WT) or MasR-deficient mice (MasR-/- or MasR+/-) at 12-14 weeks (young) or middle age (11-12 months) (MA) were used in the study. Mobilization of lineage-negative, Sca-1-positive cKit-positive (LSK) cells in response to G-CSF or plerixafor was determined. Hindlimb ischemia (HLI) was induced by femoral artery ligation. Mobilization and blood flow recovery were monitored post-HLI. Radiation chimeras were made by lethal irradiation of WT or MasR-/- mice followed by administration of bone marrow cells from MasR-/- or WT mice, respectively. Nitric oxide (NO) generation by stromal-derived factor-1α (SDF) and mitochondrial reactive oxygen species (mitoROS) levels were determined by flow cytometry. Effect of A779 treatment on mobilization, blood flow recovery, and NO and ROS levels were determined in young WT and MasR+/- mice. Circulating LSK cells in basal or in response to plerixafor or G-CSF or in response to ischemic injury were lower in MasR-/- mice compared to the WT. Responses in MasR+/- mice were similar to the WT at young age but at the middle age, impairments were observed. Impaired mobilization to ischemia or G-CSF was rescued in WT → MasR-/- chimeras. NO levels were lower and mitoROS were higher in MasR-/- LSK cells compared to WT cells. A779 precipitated dysfunctions in young-MasR+/- mice similar to that observed in MA-MasR+/-, and this accompanied decreased NO generation by SDF and enhanced mitoROS levels. This study shows that mice at MA do not exhibit vasoreparative dysfunction. Either partial or total loss of MasR precipitates advanced-aging phenotype likely due to lack of NO and oxidative stress.
© 2021. The Author(s), under exclusive licence to American Aging Association.

Entities:  

Keywords:  Aging; Ischemia; Mas receptor; Vasculogenic progenitor cells

Mesh:

Substances:

Year:  2021        PMID: 34661816      PMCID: PMC8810970          DOI: 10.1007/s11357-021-00473-4

Source DB:  PubMed          Journal:  Geroscience        ISSN: 2509-2723            Impact factor:   7.713


  75 in total

1.  Hierarchy of molecular-pathway usage in bone marrow homing and its shift by cytokines.

Authors:  Halvard Bonig; Gregory V Priestley; Thalia Papayannopoulou
Journal:  Blood       Date:  2005-09-01       Impact factor: 22.113

2.  G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanism.

Authors:  Benjamin J Capoccia; Rebecca M Shepherd; Daniel C Link
Journal:  Blood       Date:  2006-05-30       Impact factor: 22.113

3.  Altered regional blood flow distribution in Mas-deficient mice.

Authors:  Giancarla Aparecida Botelho-Santos; Michael Bader; Nathalia Alenina; Robson Augusto Souza Santos
Journal:  Ther Adv Cardiovasc Dis       Date:  2012-10

4.  Obese diabetic mouse environment differentially affects primitive and monocytic endothelial cell progenitors.

Authors:  Ola Awad; Chunhua Jiao; Ning Ma; Martine Dunnwald; Gina C Schatteman
Journal:  Stem Cells       Date:  2005-04       Impact factor: 6.277

5.  Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells.

Authors:  Alexandra Aicher; Christopher Heeschen; Christiane Mildner-Rihm; Carmen Urbich; Christian Ihling; Katja Technau-Ihling; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Nat Med       Date:  2003-10-12       Impact factor: 53.440

6.  Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling.

Authors:  Lucíola S Barcelos; Cécile Duplaa; Nicolle Kränkel; Gallia Graiani; Gloria Invernici; Rajesh Katare; Mauro Siragusa; Marco Meloni; Ilaria Campesi; Manuela Monica; Andreas Simm; Paola Campagnolo; Giuseppe Mangialardi; Lara Stevanato; Giulio Alessandri; Costanza Emanueli; Paolo Madeddu
Journal:  Circ Res       Date:  2009-04-02       Impact factor: 17.367

7.  Protective effect of long-term angiotensin II inhibition.

Authors:  Nidia Basso; Rosa Cini; Adriana Pietrelli; León Ferder; Norberto A Terragno; Felipe Inserra
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-06-08       Impact factor: 4.733

Review 8.  Hematopoietic stem cell mobilization: updated conceptual renditions.

Authors:  H Bonig; T Papayannopoulou
Journal:  Leukemia       Date:  2012-09-06       Impact factor: 11.528

9.  Disruption of the Ang II type 1 receptor promotes longevity in mice.

Authors:  Ariela Benigni; Daniela Corna; Carla Zoja; Aurelio Sonzogni; Roberto Latini; Monica Salio; Sara Conti; Daniela Rottoli; Lorena Longaretti; Paola Cassis; Marina Morigi; Thomas M Coffman; Giuseppe Remuzzi
Journal:  J Clin Invest       Date:  2009-02-09       Impact factor: 14.808

10.  Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist.

Authors:  Hal E Broxmeyer; Christie M Orschell; D Wade Clapp; Giao Hangoc; Scott Cooper; P Artur Plett; W Conrad Liles; Xiaxin Li; Barbara Graham-Evans; Timothy B Campbell; Gary Calandra; Gary Bridger; David C Dale; Edward F Srour
Journal:  J Exp Med       Date:  2005-04-18       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.